Piopar-MF 15 Tablet ER
By Piopar-MF
Rx
10 Tablet ER in a Strip

Composition
Pioglitazone(15mg) + Metformin(500mg)

Manufacturer - Mitoch Pharma Pvt Ltd
F19, F20, F21, Kohinoor Mall, Opp. Don Bosco Engineering College, Kirol Road, Kurla (W), Mumbai - 400 070

Expires on or after
July, 2025

liver
When taking Piopar-MF 15 Tablet ER and you have liver disease, be cautious. It may be necessary to adjust the dose of Piopar-MF 15 Tablet ER if you have liver issues. Always consult your doctor for guidance. Typically, Piopar-MF 15 Tablet ER is initially prescribed at a low dose for individuals with mild to moderate liver disease. However, it is advised not to use this medication if you have severe liver disease. It's important to prioritize your liver health when using Piopar-MF 15 Tablet ER.

kidney
Piopar-MF 15 Tablet ER requires caution in patients with kidney disease. Dose adjustment may be necessary, and it is not recommended for severe kidney disease. Regular kidney function monitoring is important during the treatment. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Piopar-MF 15 Tablet ER.

driving
When taking Piopar-MF 15 Tablet ER, be cautious about your blood sugar levels. Avoid driving if you experience low or high blood sugar symptoms to ensure safe driving.

pregnancy
Piopar-MF 15 Tablet ER may be unsafe during pregnancy. Animal studies have shown harmful effects on the developing baby. Consult your doctor before using to weigh the benefits and potential risks.

breastfeeding
Caution is advised when breastfeeding while taking Piopar-MF 15 Tablet ER, as it is likely unsafe and may pass into breastmilk, potentially harming the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹79
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024